UroGen Pharma(URGN) - 2022 Q4 - Earnings Call Transcript

UroGen Pharma Ltd. (NASDAQ:URGN) Q4 2022 Earnings Conference Call March 16, 2023 10:00 AM ET Company Participants Vincent Perrone – Head-Investor Relations Liz Barrett – President and Chief Executive Officer Mark Schoenberg – Chief Medical Officer Jeff Bova – Chief Commercial Officer Don Kim – Chief Financial Officer Conference Call Participants Leland Gershell – Oppenheimer Mitchell Kapoor – HCW Matt Kaplan – Ladenburg Thalmann Operator Good day and thank you for standing by. And welcome to the UroGen Phar ...